Alaunos Therapeutics, Inc.
Key Metrics
Market Snapshot
About
Alaunos Therapeutics, Inc. is a clinical-stage cell therapy company focused on developing adoptive T cell receptor (TCR) therapies for the treatment of solid tumors. The company engineers patient T cells to recognize and attack cancer cells by targeting specific tumor-associated antigens. Alaunos is advancing multiple TCR programs for various cancer indications.